CUV 1.61% $14.68 clinuvel pharmaceuticals limited

from the uspto today , page-5

  1. 520 Posts.
    another "Pending patent application" publshed today at the USPTO titled:

    METHOD OF TREATMENT OF PHOTODERMATOSES

    A method for prophylactic or therapeutic treatment of photodermatoses that are caused or exacerbated by or associated with UVR exposure in a subject, particularly a human subject, which comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to reduce the photosensitivity of the skin of the subject.

    http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=12&f=G&l=50&d=PG01&s1=(20100513.PD.+AND+au.INCO.)&p=1&OS=pd/05/13/2010+and+icn/au&RS=(PD/20100513+AND+ICN/au)
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.